There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
"Deng, T., et al.: Life Sci., 84, 311 (2009); Horne, H., et al.: Mol. Cancer Res., 7, 199 (2009); Zinner, R., et al.: Mol. Cancer Ther., 8, 521 (2009)"
"1-(2’-Deoxy-3’,5’-di-O-toluoyl-b-D-ribofuranosyl)-2-oxo-4-amino-1,2-dihydro-1,3,5-triazine is an intermediate formed in the synthesis of 5-Aza-2’-deoxy Cytidine-15N4 (A796952), used as cancer treatment, in particular to inhibit the growth of pancreatic endocrine tumor cell lines."
Hazard Compound
Refer MSDS for complete information.
Overview
"1-(2’-Deoxy-3’,5’-di-O-toluoyl-b-D-ribofuranosyl)-2-oxo-4-amino-1,2-dihydro-1,3,5-triazine is an intermediate formed in the synthesis of 5-Aza-2’-deoxy Cytidine-15N4 (A796952), used as cancer treatment, in particular to inhibit the growth of pancreatic endocrine tumor cell lines."
![N-(2-Pyrazinylcarbonyl)-L-phenylalanyl-N-[(1R)-1-borono-3-methylbutyl]-L-phenylalaninamide-d5](https://structures.clearsynth.com/CS-T-96428.png)
![N-[1,1-Bis[(acetyloxy)methyl]-3-(4-octylphenyl)propyl]acetamide-d4](https://structures.clearsynth.com/CS-T-100972.png)
